Mineralys Therapeutics Inc
XNAS: MLYS
Mineralys Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administere...
Read More
14.49
0.61
(4.39%)
666.1K
XNAS Volume
XNAS 30 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Mineralys Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..